Skip to main content

Quest Diagnostics

Quest Diagnostics Incorporated is a leading provider of diagnostic information services that supplies clinical laboratory testing, healthcare data analysis, and professional medical examinations. The enterprise operates a vast network of patient service centers, specialized laboratories, and diagnostic testing facilities across the United States and select international locations. Its principal product and service offerings encompass routine clinical blood tests, advanced genetic and molecular diagnostics, esoteric pathology services, and diagnostic insights for physicians and health systems. Revenue is primarily driven by fee-for-service testing revenues paid by commercial health insurers, government healthcare programs, and individual patients. As one of the largest diagnostic testing companies globally, the enterprise handles millions of patient specimens annually. Headquartered in Secaucus, New Jersey, Quest Diagnostics Inc. is publicly listed on the New York Stock Exchange under the ticker symbol DGX.

50 of the funds FundTelligence covers report a position in Quest Diagnostics.

Legal name
Quest Diagnostics Inc.
Sector
Health Care
Country
United States
Funds holding it
50
Exposure themes
Diagnostics and screening, Prevention, Women's Health

Funds holding Quest Diagnostics

Showing the 8 largest of 50 funds holding it.

Loading...